TAMMY WILLIAMS: Open Payments
NPI 1578951372 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,162 in 49 payments from 12 companies in 2025. Trend: 2023 $1,196 · 2024 $737 · 2025 $1,162
Food & beverage: $1,162
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 8 | $326 |
| PFIZER INC. | 15 | $246 |
| BridgeBio Pharma, Inc. | 5 | $189 |
| Novartis Pharmaceuticals Corporation | 6 | $124 |
| Actelion Pharmaceuticals US, Inc. | 4 | $88 |
| Merck Sharp & Dohme LLC | 4 | $63 |
| Philips North America LLC | 2 | $33 |
| HEARTFLOW, INC. | 1 | $25 |
| Novo Nordisk Inc | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: AMVUTTRA, Attruby, VYNDAQEL, LEQVIO, VERQUVO, ELIQUIS, UPTRAVI, OPSUMIT.
Industry payments across AR — which companies pay providers there.
